General Obstetrics and Gynecology ObstetricsAspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis☆,☆☆
Section snippets
Data sources
A search of the literature was done for studies that involved the effects of aspirin on the outcome of pregnancy. The following OVID (4.3.0) databases (and relevant segment dates) were searched electronically by a professional librarian in October 2000: MEDLINE (1966-2000), EMBASE (1980-2000), TOXLINE (1994-2000), and the EBM Reviews—Cochrane Database of Systematic Reviews (1991-2000). The MEDLINE search was repeated in April 2001. Reprotox (Reproductive Toxicology Center, Bethesda, Md; 2000),
Results
On the basis of our search strategy, 1902 citations were identified; their titles and abstracts were reviewed. Of these citations, 180 studies were selected for detailed review. Twenty-two of these studies met the inclusion criteria: 15 case-control studies,4, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 29, 30, 31, 32 6 cohort studies,2, 3, 33, 34, 35, 36 and 1 randomized control trial.25 Characteristics of the included studies are presented in the Table.
Comment
When a drug that is commonly used by pregnant women has detrimental effects (even if they are small) on pregnancy outcome, that drug may have a significant impact on public health. Although such an effect of aspirin has been suggested,17 a large cohort study3 of >50,000 women, almost 15,000 of whom were exposed to aspirin during their first trimester, found no evidence of such an effect. When all the results of the studies that were selected for this meta-analysis were combined, we could not
Acknowledgements
We thank Editorial Services, the Hospital for Sick Children, Toronto, Ontario, Canada, for assistance in the preparation of this manuscript. E. K. was a fellow of the Research Training Centre, the Hospital for Sick Children; G. K. is a senior scientist of the Canadian Institute for Health Research and holder of the Research Leadership for Better Pharmacotherapy during Pregnancy and Lactation.
References (42)
- et al.
Aspirin and congenital malformations
Lancet
(1976) - et al.
Prevention of pre-eclampsia by early antiplatelet therapy
Lancet
(1985) - et al.
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
Am J Obstet Gynecol
(2000) - et al.
Maternal influenza, drug consumption, and congenital defects of the central nervous system
Am J Obstet Gynecol
(1974) - et al.
Study of developmental abnormalities and deaths after human zygote exposure
Mutat Res
(1995) - et al.
Fetal effects of regular salicylate ingestion in pregnancy
Lancet
(1975) Congenital malformations and environmental influences in pregnancy
Br J Prev Soc Med
(1969)- et al.
Use of prescription drugs in the first trimester and congenital malformations
Aust N Z J Obstet Gynaecol
(1991) - et al.
The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects
N Engl J Med
(1989) - et al.
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies
Am J Perinatol
(1992)
Prevention of miscarriage in antiphospholipid syndrome
Autoimmunity
Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: Preconception versus postconception treatment
Am J Obstet Gynecol
A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation
Br J Obstet Gynaecol
A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease
JAMA
CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
Lancet
Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains
J Toxicol Environ Health
Aspirin-induced teratogenesis: A unique pattern of cell death and subsequent polydactyly in the rat
J Exp Zool
Aspirin: Teratogenic evaluation in the dog
Teratology
Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy
N Engl J Med
Maternal flu, fever, and the risk of neural tube defects: A population-based case-control study
Am J Epidemiol
A retrospective enquiry into possible teratogenic effects of drugs in pregnancy
Adv Exp Med Biol
Cited by (0)
- ☆
Supported by a grant from Pfizer, Inc, Groton, Conn, and Fetox International, Inc, Toronto, Ontario.
- ☆☆
Reprint requests: Gideon Koren, MD, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada. E-mail: [email protected]